Alaunos Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $106.3M
Liabilities Breakdown FY2016
Total Liabilities: $58.3M
Asset Breakdown
Total Assets: $106.3M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $81.1M | 76.2% |
| Accounts Receivable | $21.0K | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $843.0K | 0.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $24.4M | 23.0% |
Liabilities Breakdown
Total Liabilities: $58.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $156.0K | 0.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $58.2M | 99.7% |